Stephanie Bova

Stephanie Bova currently serves as Corporate Vice President and Digital Transformation Officer for Drug Development at Novo Nordisk, overseeing the digital strategy and execution. Additionally, Stephanie is a Non-Executive Board Member at Adragos Pharma, a global pharmaceutical CDMO. Previous roles include Head of Digital Strategy and Innovation at BD, Advisory Board Member at Terra Lumina, and various leadership positions at Novartis, including VP of Redefining Drug Development and VP of Digital Program Head in Oncology. Prior experience also includes key positions at Takeda, including Global Head of Digital Alliances & Ventures and involvement with multiple healthcare startups such as Gaido Health and Oshi Health. Stephanie holds an MBA from the University of Maryland Global Campus and has completed an executive education course in Data Science from Johns Hopkins University.